# THERAVANCE BIOPHARMA INC (TBPH)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/TBPH/

- Reporting holders: 180
- Reported value: $856.1M
- Shares held by institutions: 50,147,181 of 51,918,754 outstanding
- Held through calls: 0.0%
- Held through puts: 0.4%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Madison Avenue Partners, LP](https://holderbook.com/funds/1801265-madison-avenue-partners-lp/) | $156.6M | 9,212,252 | 6.7% | 20 |
| [Weiss Asset Management LP](https://holderbook.com/funds/1357550-weiss-asset-management-lp/) | $126.8M | 7,457,060 | 1.3% | 19 |
| [BlackRock, Inc.](https://holderbook.com/funds/2012383-blackrock-inc/) | $77.6M | 4,562,487 | 0.0% | 8 |
| [Newtyn Management, LLC](https://holderbook.com/funds/1569241-newtyn-management-llc/) | $58.4M | 3,434,191 | 7.3% | 20 |
| [Irenic Capital Management LP](https://holderbook.com/funds/1929389-irenic-capital-management-lp/) | $46.9M | 2,760,948 | 2.3% | 15 |
| [STATE STREET CORP](https://holderbook.com/funds/93751-state-street-corp/) | $45.2M | 2,657,168 | 0.0% | 31 |
| [VANGUARD CAPITAL MANAGEMENT LLC](https://holderbook.com/funds/2100119-vanguard-capital-management-llc/) | $30.1M | 1,771,493 | 0.0% | 2 |
| [TWO SIGMA INVESTMENTS, LP](https://holderbook.com/funds/1179392-two-sigma-investments-lp/) | $20.8M | 1,225,587 | 0.0% | 5 |
| [D. E. Shaw & Co., Inc.](https://holderbook.com/funds/1009207-d-e-shaw-co-inc/) | $20.2M | 1,185,390 | 0.0% | 20 |
| [ACADIAN ASSET MANAGEMENT LLC](https://holderbook.com/funds/916542-acadian-asset-management-llc/) | $20.0M | 1,174,910 | 0.0% | 8 |
| [GEODE CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1214717-geode-capital-management-llc/) | $19.0M | 1,117,895 | 0.0% | 31 |
| [CITADEL ADVISORS LLC](https://holderbook.com/funds/1423053-citadel-advisors-llc/) | $18.3M | 1,013,336 | 0.0% | 20 |
| [DIMENSIONAL FUND ADVISORS LP](https://holderbook.com/funds/354204-dimensional-fund-advisors-lp/) | $17.7M | 1,043,051 | 0.0% | 13 |
| [MACKENZIE FINANCIAL CORP](https://holderbook.com/funds/919859-mackenzie-financial-corp/) | $16.8M | 985,848 | 0.0% | 3 |
| [MORGAN STANLEY](https://holderbook.com/funds/895421-morgan-stanley/) | $12.0M | 705,202 | 0.0% | 35 |
| [Oasis Management Co Ltd.](https://holderbook.com/funds/1317904-oasis-management-co-ltd/) | $9.9M | 583,490 | 0.5% | 16 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $8.3M | 488,309 | 0.0% | 31 |
| [Qube Research & Technologies Ltd](https://holderbook.com/funds/1729829-qube-research-technologies-ltd/) | $7.3M | 429,813 | 0.0% | 6 |
| [NORTHERN TRUST CORP](https://holderbook.com/funds/73124-northern-trust-corp/) | $6.9M | 404,356 | 0.0% | 31 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](https://holderbook.com/funds/2100121-vanguard-portfolio-management-llc/) | $6.7M | 394,158 | 0.0% | 2 |
| [Jupiter Topco LLC](https://holderbook.com/funds/2146052-jupiter-topco-llc/) | $6.6M | 387,493 | 0.0% | 1 |
| [GOLDMAN SACHS GROUP INC](https://holderbook.com/funds/886982-goldman-sachs-group-inc/) | $5.8M | 339,960 | 0.0% | 31 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](https://holderbook.com/funds/884546-charles-schwab-investment-management-inc/) | $5.5M | 321,154 | 0.0% | 31 |
| [Sixth Street Partners Management Company, L.P.](https://holderbook.com/funds/1812095-sixth-street-partners-management-company-l-p/) | $5.5M | 321,154 | 0.0% | 1 |
| [GLAZER CAPITAL, LLC](https://holderbook.com/funds/1076809-glazer-capital-llc/) | $5.1M | 301,834 | 0.1% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 180 | $856.1M |
| Q1 2026 | 172 | $821.1M |
| Q4 2025 | 171 | $931.1M |
| Q3 2025 | 162 | $718.1M |
| Q2 2025 | 137 | $519.5M |
| Q1 2025 | 132 | $401.0M |
| Q4 2024 | 129 | $422.4M |
| Q3 2024 | 119 | $372.0M |
| Q2 2024 | 131 | $401.8M |
| Q1 2024 | 122 | $438.4M |
| Q4 2023 | 119 | $554.5M |
| Q3 2023 | 115 | $439.7M |